Return On Equity in % of Editas Medicine, Inc. from Q3 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Editas Medicine, Inc. quarterly and annual Return On Equity history and change rate from Q3 2016 to Q3 2025.
  • Editas Medicine, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -349%, a 335% decline year-over-year.
  • Editas Medicine, Inc. annual Return On Equity for 2024 was -113%, a 164% decline from 2023.
  • Editas Medicine, Inc. annual Return On Equity for 2023 was -43%, a 15% increase from 2022.
  • Editas Medicine, Inc. annual Return On Equity for 2022 was -50%, a 56% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Editas Medicine, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -349% -268% -335% 01 Jul 2025 30 Sep 2025
Q2 2025 -242% -179% -287% 01 Apr 2025 30 Jun 2025
Q1 2025 -166% -119% -251% 01 Jan 2025 31 Mar 2025
Q4 2024 -113% -70% -164% 01 Oct 2024 31 Dec 2024
Q3 2024 -80% -26% -48% 01 Jul 2024 30 Sep 2024
Q2 2024 -63% -7.5% -14% 01 Apr 2024 30 Jun 2024
Q1 2024 -47% +8.9% +16% 01 Jan 2024 31 Mar 2024
Q4 2023 -43% +7.3% +15% 01 Oct 2023 31 Dec 2023
Q3 2023 -54% -13% -31% 01 Jul 2023 30 Sep 2023
Q2 2023 -55% -20% -58% 01 Apr 2023 30 Jun 2023
Q1 2023 -56% -23% -71% 01 Jan 2023 31 Mar 2023
Q4 2022 -50% -18% -56% 01 Oct 2022 31 Dec 2022
Q3 2022 -41% -3% -8% 01 Jul 2022 30 Sep 2022
Q2 2022 -35% -2.9% -9% 01 Apr 2022 30 Jun 2022
Q1 2022 -33% -4.4% -16% 01 Jan 2022 31 Mar 2022
Q4 2021 -32% -1.2% -3.8% 01 Oct 2021 31 Dec 2021
Q3 2021 -38% -12% -43% 01 Jul 2021 30 Sep 2021
Q2 2021 -32% +15% +31% 01 Apr 2021 30 Jun 2021
Q1 2021 -28% +35% +55% 01 Jan 2021 31 Mar 2021
Q4 2020 -31% +30% +49% 01 Oct 2020 31 Dec 2020
Q3 2020 -27% +30% +53% 01 Jul 2020 30 Sep 2020
Q2 2020 -47% +0.89% +1.9% 01 Apr 2020 30 Jun 2020
Q1 2020 -63% -16% -33% 01 Jan 2020 31 Mar 2020
Q4 2019 -61% -14% -29% 01 Oct 2019 31 Dec 2019
Q3 2019 -57% -3.4% -6.4% 01 Jul 2019 30 Sep 2019
Q2 2019 -47% +14% +23% 01 Apr 2019 30 Jun 2019
Q1 2019 -48% +11% +19% 01 Jan 2019 31 Mar 2019
Q4 2018 -47% +15% +24% 01 Oct 2018 31 Dec 2018
Q3 2018 -53% +17% +24% 01 Jul 2018 30 Sep 2018
Q2 2018 -61% +6.5% +9.6% 01 Apr 2018 30 Jun 2018
Q1 2018 -59% +4.6% +7.2% 01 Jan 2018 31 Mar 2018
Q4 2017 -62% -5.9% -10% 01 Oct 2017 31 Dec 2017
Q3 2017 -70% -11% -19% 01 Jul 2017 30 Sep 2017
Q2 2017 -68% 01 Apr 2017 30 Jun 2017
Q1 2017 -63% 01 Jan 2017 31 Mar 2017
Q4 2016 -56% 01 Oct 2016 31 Dec 2016
Q3 2016 -59% 01 Jul 2016 30 Sep 2016

Editas Medicine, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -113% -70% -164% 01 Jan 2024 31 Dec 2024
2023 -43% +7.3% +15% 01 Jan 2023 31 Dec 2023
2022 -50% -18% -56% 01 Jan 2022 31 Dec 2022
2021 -32% -1.2% -3.8% 01 Jan 2021 31 Dec 2021
2020 -31% +30% +49% 01 Jan 2020 31 Dec 2020
2019 -61% -14% -29% 01 Jan 2019 31 Dec 2019
2018 -47% +15% +24% 01 Jan 2018 31 Dec 2018
2017 -62% -5.9% -10% 01 Jan 2017 31 Dec 2017
2016 -56% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.